Sentinus, LLC
- SEC CIK
- 0001811345
- Latest filing
- Aug 11, 2026
ATNM holding history
Actinium Pharmaceuticals, Inc. in every 13F filed by Sentinus, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATNM overviewAll 13F holders of ATNMFull Q2 2026 holdings
- Shares (Q2 2023)
- 167,275
- Value
- $1.24M
- % of portfolio
- 0.4%
- Quarters held
- 4
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | – | – | – | – | Not filed | Holders |
| Q2 2023 | 167,275 | $1.24M | 0.4% | +18,225+12.2% | Added | Holders |
| Q1 2023 | 149,050 | $1.41M | 0.5% | +126,050+548.0% | Added | Holders |
| Q4 2022 | 23,000 | $271.6K | 0.2% | +500+2.2% | Added | Holders |
| Q3 2022 | 22,500 | $166.0K | 0.1% | – | No prior filing | Holders |